[바이오스토리] [creativebiolabs] Anti-HumanRSPO3 Therapeutic Antibody
작성자 | 관리자 | 작성일 | 2020-06-22 |
조회수 | 5,795회 | 댓글 | 0 |
본문
바이오스토리에서 "creativebiolabs" 직수입 합니다.
많은 견적 문의 부탁드립니다^^
Anti-Human RSPO3 Therapeutic Antibody (Rosmantuzumab) (CAT#: TAB-449CQ)
Recombinant monoclonal antibody to RSPO3. Rosmantuzumab is a humanized monoclonal antibody that can be potentially used in the treatment of Advanced Relapsed Tumor, Refractory Solid Tumors.
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Humanized
- Type
- IgG1, κ
- Specificity
- Human RSPO3
- Species Reactivity
- Human
- Applications
- ELISA, IHC, FC, IP, IF, FuncS *
- Conjugate
- Unconjugated
- CAS
- 1684393-04-1
- Generic Name
- Rosmantuzumab
- UNII
- VD026R6TCI
- Related Disease
- Advanced Relapsed Tumor, Refractory Solid Tumors
Applications
- Application Notes
- The RSPO3 antibody has been reported in applications of Neut.
Target
- Alternative Names
- RSPO3; R-spondin 3; PWTSR; THSD2; CRISTIN1; R-spondin-3; R-spondin 3 homolog; roof plate-specific spondin-3; protein with TSP type-1 repeat; thrombospondin, type I, domain containing 2; thrombospondin type-1 domain-containing protein 2
- Gene ID
- 84870
- UniProt ID
- Q9BXY4
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
바이오스토리에서 "creativebiolabs" 직수입 합니다.
많은 견적 문의 부탁드립니다^^